Dr Reddys (RDY) quality head reports direct holding of 35,600 shares

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD executive Munnirpallam Madhu Sundar Subramanian, Global Head of Quality and PV, filed an initial ownership report showing his current stake in the company. The Form 3 lists direct ownership of 35,600 Equity Shares, without indicating any recent purchase or sale activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN

Role Global Head of Quality and PV

Type	Security	Shares	Price	Value
holding	Equity Shares	--	--	--

Holdings After Transaction: Equity Shares — 35,600 shares (Direct)

Footnotes (1)

Key Figures

Equity Shares owned: 35,600 Equity Shares

1 metrics

Equity Shares owned 35,600 Equity Shares Direct beneficial ownership reported on Form 3

Key Terms

Form 3, Equity Shares, Global Head of Quality and PV

3 terms

Form 3 regulatory

"filed an initial ownership report showing his current stake"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Equity Shares financial

"The Form 3 lists direct ownership of 35,600 Equity Shares"

Equity shares are units of ownership in a company that give the holder a claim on a portion of its assets and profits, like owning a slice of a business. They matter to investors because their value can rise or fall with the company’s performance and market sentiment, may provide periodic income through dividends, and often carry voting rights that influence how the business is run.

Global Head of Quality and PV financial

"executive, Global Head of Quality and PV, filed an initial ownership report"

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN

(Last) (First) (Middle)

B-201, GOLDEN HABITAT, BP RAJU MARG

WHITEFEILDS, KONDAPUR

(Street)

HYDERABAD TELANGANA 500084

(City) (State) (Zip)

INDIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Head of Quality and PV

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Equity Shares	35,600	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ MADHU SUNDAR SUBRAMANIAN MUNNIRPALLAM	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the RDY Form 3 filing by Munnirpallam Madhu Sundar Subramanian show?

The Form 3 shows his existing ownership in DR REDDYS LABORATORIES LTD, reporting direct holdings of 35,600 Equity Shares. It is an initial beneficial ownership statement and does not itself indicate a new purchase or sale.

How many DR REDDYS (RDY) shares does this executive report owning?

The filing reports that he directly owns 35,600 Equity Shares of DR REDDYS LABORATORIES LTD. This figure reflects his beneficial ownership as disclosed in the initial Form 3 submission.

Did the RDY Form 3 disclose any recent insider buying or selling?

No specific buying or selling is detailed. The Form 3 serves as an initial ownership report, listing 35,600 Equity Shares held directly, rather than documenting a new transaction in the company’s stock.

What is the role of the insider in DR REDDYS LABORATORIES LTD?

The reporting person is the Global Head of Quality and PV at DR REDDYS LABORATORIES LTD. The filing links this senior executive role to his reported direct holding of 35,600 Equity Shares.

Is the ownership in RDY shares held directly or indirectly by the executive?

The Form 3 describes the 35,600 Equity Shares as held under direct ownership. This means the holdings are attributed personally to the reporting executive, rather than through an intermediary entity.